These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 36384307)

  • 21. Prescribing meaning: hedonistic perspectives on the therapeutic use of psychedelic-assisted meaning enhancement.
    Miceli McMillan R
    J Med Ethics; 2021 Oct; 47(10):701-705. PubMed ID: 33148774
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A dangerous method? Psychedelic therapy at Modum Bad, Norway, 1961-76.
    Johnstad PG
    Hist Psychiatry; 2020 Jun; 31(2):217-226. PubMed ID: 31928087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Virtual Reality as a Moderator of Psychedelic-Assisted Psychotherapy.
    Sekula AD; Downey L; Puspanathan P
    Front Psychol; 2022; 13():813746. PubMed ID: 35310225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Psychedelic Group Therapy.
    Gasser P
    Curr Top Behav Neurosci; 2022; 56():23-34. PubMed ID: 35091980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perceived outcomes of psychedelic microdosing as self-managed therapies for mental and substance use disorders.
    Lea T; Amada N; Jungaberle H; Schecke H; Scherbaum N; Klein M
    Psychopharmacology (Berl); 2020 May; 237(5):1521-1532. PubMed ID: 32043165
    [TBL] [Abstract][Full Text] [Related]  

  • 26. On the need for metaphysics in psychedelic therapy and research.
    Sjöstedt-Hughes P
    Front Psychol; 2023; 14():1128589. PubMed ID: 37063525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The psychedelic drug therapies.
    Grinspoon L; Bakalar JB
    Curr Psychiatr Ther; 1981; 20():275-83. PubMed ID: 7326971
    [No Abstract]   [Full Text] [Related]  

  • 28. Knowing and being known: Psychedelic-assisted psychotherapy and the sense of authenticity.
    Fischman LG
    Front Psychiatry; 2022; 13():933495. PubMed ID: 36203843
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fostering Nurse Engagement in Psychedelic-Assisted Therapies for Patients with Serious Illness.
    Rosa WE; Dorsen CG; Penn A
    J Palliat Med; 2020 Oct; 23(10):1288-1289. PubMed ID: 33001753
    [No Abstract]   [Full Text] [Related]  

  • 30. Research into Psychedelic-Assisted Psychotherapy for Anorexia Nervosa Should be Funded.
    Otterman LS
    J Bioeth Inq; 2023 Mar; 20(1):31-39. PubMed ID: 36534233
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The future of hallucination research: Can hallucinogens and psychedelic drugs teach us anything?
    Waters F
    Psychiatry Res; 2023 Jan; 319():114968. PubMed ID: 36462291
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Great Expectations: recommendations for improving the methodological rigor of psychedelic clinical trials.
    Aday JS; Heifets BD; Pratscher SD; Bradley E; Rosen R; Woolley JD
    Psychopharmacology (Berl); 2022 Jun; 239(6):1989-2010. PubMed ID: 35359159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modalities of the psychedelic experience: Microclimates of set and setting in hallucinogen research and culture.
    Hartogsohn I
    Transcult Psychiatry; 2022 Oct; 59(5):579-591. PubMed ID: 35818775
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peak experiences and the afterglow phenomenon: when and how do therapeutic effects of hallucinogens depend on psychedelic experiences?
    Majić T; Schmidt TT; Gallinat J
    J Psychopharmacol; 2015 Mar; 29(3):241-53. PubMed ID: 25670401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Gratuitous Grace: The Influence of Religious Set and Intent on the Psychedelic Experience.
    Neitzke-Spruill L; Glasser C
    J Psychoactive Drugs; 2018; 50(4):314-321. PubMed ID: 30052496
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Psychedelic-assisted therapy for functional neurological disorders: A theoretical framework and review of prior reports.
    Stewart B; Dean JG; Koek A; Chua J; Wabl R; Martin K; Davoodian N; Becker C; Himedan M; Kim A; Albin R; Chou KL; Kotagal V
    Pharmacol Res Perspect; 2020 Dec; 8(6):e00688. PubMed ID: 33280274
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression.
    Murphy R; Kettner H; Zeifman R; Giribaldi B; Kartner L; Martell J; Read T; Murphy-Beiner A; Baker-Jones M; Nutt D; Erritzoe D; Watts R; Carhart-Harris R
    Front Pharmacol; 2021; 12():788155. PubMed ID: 35431912
    [No Abstract]   [Full Text] [Related]  

  • 38. The Watts Connectedness Scale: a new scale for measuring a sense of connectedness to self, others, and world.
    Watts R; Kettner H; Geerts D; Gandy S; Kartner L; Mertens L; Timmermann C; Nour MM; Kaelen M; Nutt D; Carhart-Harris R; Roseman L
    Psychopharmacology (Berl); 2022 Nov; 239(11):3461-3483. PubMed ID: 35939083
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Psychedelics.
    Kelmendi B; Kaye AP; Pittenger C; Kwan AC
    Curr Biol; 2022 Jan; 32(2):R63-R67. PubMed ID: 35077687
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of recreational psychedelic substance use experiences classified by substance.
    Hase A; Erdmann M; Limbach V; Hasler G
    Psychopharmacology (Berl); 2022 Feb; 239(2):643-659. PubMed ID: 35031816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.